Chiral
amines are valuable constituents of many important pharmaceutical
compounds and their intermediates. It is estimated that ∼40%–45%
of small molecule pharmaceuticals contain chiral amine scaffolds in
their structures. The major challenges encountered in the chemical
synthesis of enantiopure amines are the use of toxic chemicals, the
formation of a large number of byproducts, and multistep syntheses.
To address these limitations, cost-effective biocatalytic methods
are maturing and proving to be credible alternatives for the synthesis
of chiral amines in enantiomerically pure forms. Herein, we report
the recent progress achieved and current perspectives in the enzymatic
synthesis of chiral amines using four important enzymes, i.e., imine
reductases, amine dehydrogenases, monoamine oxidases, and cytochrome
P450s. Applications to the industrial synthesis of chiral amines are
highlighted. Protein engineering approaches, which play a critical
role in improving or altering enzyme activity and substrate scope,
are also addressed, along with the discovery of pioneering enzymatic
activities from nature. This survey of recent work demonstrates that
enzymatic approaches to the synthesis of chiral amines will continue
to be a major focus of research in biocatalytic chemistry in the years
to come.